Treatment failure gout.
Saman Ali, Edward V. Lally
Abstract
Saman Ali, Edward V. Lally
Abstract
Treatment options for gout are well established and reasonably effective.1 They include anti-inflammatory agents such as non-steroidal anti-inflammatory drugs (NSAIDS), glucocorticoids and colchicine and urate-lowering therapies such as allopurinol and probenecid. However, despite the availability of effec-tive urate-lowering therapy, there remains a subset of patients with gout who, de-spite aggressive therapy, have intractable disease, manifest as recurrent gout flares, chronic arthritis and progressive topha-ceous deposits. These patients are referred to as having “refractory gout ” or “treat-
OpenAlex reports 11 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Treatment options for gout are well established and reasonably effective.1 They include anti-inflammatory agents such as non-steroidal anti-inflammatory drugs (NSAIDS), glucocorticoids and colchicine and urate-lowering therapies such as allopurinol and probenecid. However, despite the availability of effec-tive urate-lowering therapy, there remains a subset of patients with gout who, de-spite aggressive therapy, have intractable disease, manifest as recurrent gout flares, chronic arthritis and progressive topha-ceous deposits. These patients are referred to as having “refractory gout ” or “treat-
Key concepts: Febuxostat, Gout, Allopurinol, Medicine, Benzbromarone, Probenecid, Xanthine oxidase inhibitor, Xanthine oxidase